Eli Lilly and Company - Cash Flows Other Operating

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cash-Flows-Other-Operating" stands at -1.93 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2023.

Eli Lilly and Company's third quarter result of 0.5014 Billion USD for the item "Cash Flows Other Operating" represents an increase of 146.92 percent compared to it's second quarter result.

Also, Eli Lilly and Company's third quarter result of 0.5014 Billion USD for the item "Cash Flows Other Operating" represents an increase of 216.66 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Eli Lilly and Company's third quarter result of -1.93 Billion USD for the item "Cash Flows Other Operating" represents an increase of 32.60 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.297 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.297 Billion United States Dollars.
The 3 year change is 0.3625 Billion United States Dollars.
The 5 year change is -2.08 Billion United States Dollars.
The 10 year change is -1.03 Billion United States Dollars.

The Serie's long term average value is -0.683 Billion United States Dollars. It's latest available value, on 09/30/2025, is -1.24 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is +0.9312 Billion.
The Serie's change in United States Dollars from it's maximum value, on 09/30/2013, to it's latest available value, on 09/30/2025, is -2.65 Billion.